NEXGEL Announces Distribution Of Histasolv Under Partnership With STADA Arzneimittel AG; Europe's Top DAO Enzyme Supplement For Histamine Food Intolerance Now Available Through NEXGEL
Portfolio Pulse from Benzinga Newsdesk
NEXGEL has announced a partnership with STADA Arzneimittel AG to distribute Histasolv, a top DAO enzyme supplement for histamine food intolerance in Europe. This product will now be available through NEXGEL.
June 11, 2024 | 12:41 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
NEXGEL has partnered with STADA Arzneimittel AG to distribute Histasolv, a leading DAO enzyme supplement for histamine food intolerance in Europe. This partnership could enhance NEXGEL's product portfolio and market reach.
The partnership with STADA to distribute a leading enzyme supplement can significantly enhance NEXGEL's product offerings and market presence, potentially driving revenue growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100